Diagnos Laboratorium Utama Tbk. vs Teknologi Karya Digital Nusa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Teknologi Karya Digital Nusa Tbk. trades at Rp101 (market cap 298.08B, 3.5M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Teknologi Karya Digital Nusa Tbk. are close in size by market cap, and Teknologi Karya Digital Nusa Tbk. is more actively traded (3.5M versus 41.7K). Which is the better fit depends on your goals.
| DGNS | TRON | |
|---|---|---|
Market Cap | 316.25B | 298.08B |
Volume | 41.7K | 3.5M |
Lot | 417 | 35.01K |
Turnover | 9.66M | 352.27M |
Average Price | 231.65 | 100.63 |
Value | 9.66M | 352.27M |
Indicative Equilibrium Price | 230 | 101 |
Indicative Equilibrium Volume | 2.4K | 240 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Teknologi Karya Digital Nusa Tbk (formerly PT Damai Harapan Sentosa) (the Entity) wasestablished based on Notarial Deed No. 25 dated January 7, 2011 of Tjoa Karina Juwita SH., Notaryin Jakarta. The Entity started its commercial operations in 2015. PT Teknologi Karya Digital Nusa Tbk is the parent entity, whereas David Santoso is the ultimate beneficial owner starting from 2020.
Read more on TRON →